Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis Press Release
Dianthus Therapeutics Early GO Decision in CAPTIVATE CIDP Trial Mar 9, 2026 8:00 AM EDT Webcast Supporting Materials CAPTIVATE Go Decision Interim Responder Analysis 1.2 MB
